These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24251833)

  • 1. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
    Shehata HS; El-Tamawy MS; Shalaby NM; Ramzy G
    J Headache Pain; 2013 Nov; 14(1):92. PubMed ID: 24251833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ; Lian YJ; Zheng YK; Zhang HF; Chen Y; Xie NC; Wang LJ
    Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
    Zhang H; Lian Y; Ma Y; Chen Y; He C; Xie N; Wu C
    J Headache Pain; 2014 Sep; 15(1):65. PubMed ID: 25263254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J; Zhu X; Yang G; Shen J; Xie P; Zuo X; Xia L; Han Q; Zhao Y
    Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B; Motamedi MH; Bagheri SC; Bayat M; Lassemi E; Navi F; Moharamnejad N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):47-50. PubMed ID: 20674409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin and intractable trigeminal neuralgia.
    Türk U; Ilhan S; Alp R; Sur H
    Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia: An Update on Systematic Review With Meta-analyses.
    Hu X; Xia Y; Li J; Wang X; Liu H; Hu J; Bi J; Wu J; Wang T; Lin Z; Xiong N
    Clin J Pain; 2024 Jun; 40(6):383-392. PubMed ID: 38385501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin as an Effective Treatment for Trigeminal Neuralgia in Surgical Practices.
    Tangney T; Heydari ES; Sheldon BL; Shetty A; Argoff CE; Khazen O; Pilitsis JG
    Stereotact Funct Neurosurg; 2022; 100(5-6):314-320. PubMed ID: 35944492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials.
    Morra ME; Elgebaly A; Elmaraezy A; Khalil AM; Altibi AM; Vu TL; Mostafa MR; Huy NT; Hirayama K
    J Headache Pain; 2016 Dec; 17(1):63. PubMed ID: 27377706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment of trigeminal neuralgia with onabotulinum toxin A.
    Zúñiga C; Piedimonte F; Díaz S; Micheli F
    Clin Neuropharmacol; 2013; 36(5):146-50. PubMed ID: 24045604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.
    Li S; Lian YJ; Chen Y; Zhang HF; Ma YQ; He CH; Wu CJ; Xie NC; Zheng YK; Zhang Y
    J Headache Pain; 2014 Jun; 15(1):43. PubMed ID: 24952600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia.
    Liu J; Xu YY; Zhang QL; Luo WF
    Pain Res Manag; 2018; 2018():7365148. PubMed ID: 29849847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C; Díaz S; Piedimonte F; Micheli F
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F; Hernando de la Bárcena I; Marzo-Sola ME
    Med Clin (Barc); 2017 Jan; 148(1):28-32. PubMed ID: 27743594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.
    Hu Y; Guan X; Fan L; Li M; Liao Y; Nie Z; Jin L
    J Headache Pain; 2013 Aug; 14(1):72. PubMed ID: 23964790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up.
    Türk Börü Ü; Duman A; Bölük C; Coşkun Duman S; Taşdemir M
    Medicine (Baltimore); 2017 Sep; 96(39):e8133. PubMed ID: 28953646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review.
    Naderi Y; Rad M; Sadatmoosavi A; Khaleghi E; Khorrami Z; Chamani G; Shabani M
    Clin Exp Dent Res; 2024 Apr; 10(2):e882. PubMed ID: 38558383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study.
    Zhang H; Lian Y; Xie N; Chen C; Zheng Y
    J Headache Pain; 2017 Aug; 18(1):81. PubMed ID: 28799056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.